Table 1.
Table showing list of existing PLD inhibitors, their abbreviations, chemical structure and isoform specificity. Also mentioned are the IC50 values.
| PHOSPHOLIPASE D (PLD) INHIBITORS | |||
|---|---|---|---|
| IUPAC name | Abbrev. name (this paper) | Chemical structure | Isoform specificity |
| N-[2-[1-(3-Fluorophenyl)-4-oxo-1,3,-8-triazaspiro[4,5]dec-8-yl]ethyl]-2-naphthalenecarboxamide. (Lavieri RR et al, J Med Chem, 2010) | NFOT |
|
PLD2 inhibitor |
| N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide. (Lewis JA et al, Bioorg Med Chem Lett, 2009) | NOPT |
|
PLD2 inhibitor |
| N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-naphthalenecarboxamide. (Lewis JA et al, Bioorg Med Chem Lett, 2009) | NBOD |
|
PLD1 inhibitor |
| (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide. (Lewis JA et al, Bioorg Med Chem Lett, 2009) | RBPC |
|
PLD1 inhibitor |
| N-[2-[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-5-fluoro-1H-indole-2-carboxamide Other name: 5-Fluoro-2-Indolyl des-Chlorohalopemide. (Su W et al, Mol Pharmacol, 2009) | FIPI |
|
Dual (PLD1 and PLD2) inhibitor |